Via American Greatness, When Congressman Thomas Massie (R-KY) contacted officials from the Centers for Disease Control and Prevention (CDC) in December of 2020, he wanted to know if taking the […]
Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
Esther E Freeman, Ignacio Garcia-Doval, Luigi Naldi, Roderick J Hay British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 1–, https://doi.org/10.1093/bjd/ljad131 In early 2020 there were reports of a new and potentially fatal […]
DERMATOLOGIC MANIFESTATIONS OF COVID-19 CAN BECOME “LONG-HAULER” SYMPTOMS
Originally published on The Lancet Infectious Disease KEY FINDINGS Study Methods In April 2020, working with the International League of Dermatological Societies and the American Academy of Dermatology, the researchers established an international registry […]
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection
Zoe O Demko, Tong Yu, Sarika K Mullapudi, M Gabriela Varela Heslin, et. al. Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae027, https://doi.org/10.1093/ofid/ofae027 Abstract Background Few longitudinal studies available characterize long COVID […]
Role of MicroRNA-21 in Regulating Intracellular Pathways Associated With Phagocytosis in Human Macrophages: An In Vitro Study
Natsuki Anada • Yoshinobu Nakayama • Jun Takeshita • Kyoko Kageyama • Hiroatsu Sakamoto • Takahiko Kamibayashi • Yasufumi Nakajima 2024, DOI: 10.7759/cureus.63736 Abstract Introduction The efficient clearance of bacteria by macrophages is crucial for the timely resolution of inflammation. In this study, […]
IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo
Shreya Ghimire, Biyun Xue, Kun Li, Ryan M Gannon, et. al.doi: https://doi.org/10.1101/2024.07.03.60194 Abstract Treatments available to prevent progression of virus-induced lung diseases, including coronavirus disease 2019 (COVID-19) are of limited benefit once respiratory failure occurs. The efficacy of approved […]
Spatial transcriptomics unveils the in situ cellular and molecular hallmarks of the lung in fatal COVID-19
Carlos Garcia-Prieto, Eva Musulen, Veronica Davalos, et. al.doi: https://doi.org/10.1101/2024.07.03.601404 00010010 Abstract Severe Coronavirus disease 2019 (COVID-19) induces heterogeneous and progressive diffuse alveolar damage (DAD) highly disrupting lung tissue architecture and homeostasis, hampering disease management and leading to […]
Pfizer Infringed On Moderna Patent With COVID-19 Vaccine: Court
JUL 05, 2024 – 07:00 PM, Authored by Zachary Stieber via The Epoch Times, Pfizer and BioNTech’s COVID-19 vaccine infringed on a patent held by rival Moderna, the High Court […]
‘Visionary’ study finds inflammation, evidence of Covid virus years after infection
By Isabella Cueto, 2024 Stat Reporting Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco. He recalls […]
COVID-19 and spinal cord injury: clinical presentation, clinical course, and clinical outcomes of people hospitalised
Inge E. Eriks-Hoogland, Michael A. Barth, Lorena L. Müller, et. al. Spinal Cord Series and Cases volume 10, Article number: 5 (2024) Abstract Study design Retrospective study Objectives To describe the presenting symptoms/signs, clinical course and outcomes in […]